Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Israel

European Innovation Council · Running

apyx The first non-surgical repair for Pelvic Organ Prolapse

Coordinator
Escala Medical Ltd, Israel
Runs
1 October 2023 to 30 September 2025
Status
Running
EU funding
€2.5m
Total cost
€5.1m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190143220

What the project is doing

In the project's own words, from its summary on CORDIS.

Pelvic Organ Prolapse (POP) affects nearly 50% of women over 40 years old globally. 89% of the cases seek treatment for symptomatic early stage prolapse. Despite the high prevalence and the progression of POP over time, patients currently cannot be offered a repair solution until the condition worsens enough for surgical intervention. However, the surgical interventions of prolapse have several side effects like prolonged recovery, pelvic pain and relapses of POP.

Escala Medical has developed a minimally invasive and incision-free repair intervention for early-stage POP repair - Apyx. Apyx is the first medical device for treating early stage prolapse, regaining quality of life and prevention of prolapse deterioration for the vast majority, currently un-addressed, POP sufferers. The EIC project will finalize the development of Apyx, conduct clinical trials, and support scale-up and commercialization activities.

Topics

Who is involved

OrganisationCityCountryRole
Escala Medical LtdMisgravIsraelCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI